Literature DB >> 21516571

Familywise error control in multi-armed response-adaptive two-stage designs.

Georg Gutjahr1, Martin Posch, Werner Brannath.   

Abstract

For comparing multiple treatments against a single control with normally distributed observations, we consider two-stage designs of the following form: During the first stage, control and treatments are allocated by response-adaptive randomization; after completion of the first stage, some treatments are selected to proceed to the second stage; during the second stage, control and selected treatments are allocated by block randomization. Tests for such designs that use the data from both stages have been based on simulation under the global null hypothesis. We present an approach that does not rely on simulation and protects the familywise error rate in the strong sense. The main idea is to view the trial as a data-dependent modification of a simpler design, for which we know the distributions of its test statistics. To account for the data-dependent modification, we use the conditional invariance principle (Brannath et al., 2007).

Mesh:

Year:  2011        PMID: 21516571     DOI: 10.1080/10543406.2011.551337

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  2 in total

1.  Familywise error control in multi-armed response-adaptive trials.

Authors:  D S Robertson; J M S Wason
Journal:  Biometrics       Date:  2019-04-03       Impact factor: 2.571

2.  Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.

Authors:  Thomas Burnett; Pavel Mozgunov; Philip Pallmann; Sofia S Villar; Graham M Wheeler; Thomas Jaki
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.